AD1 TREATMENT EXPERIENCES OF PATIENTS WITH SCHIZOPHRENIA: FINDINGS FROM A QUALITATIVE FOCUS GROUP STUDY
Leona Bessonova(Alkermes (United States)), Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), Martha Sajatovic(University Hospitals of Cleveland), Julia Carpenter-Conlin(Alkermes (United States)), Peter J. Weiden(Wilmington University), A.K. O’Sullivan(Alkermes (United States)), Michelle K. White(GroundMetrics (United States)), Cory Saucier(GroundMetrics (United States))
Cited by 1
Related Papers
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832
Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia
|Human Brain Mapping|2005|622
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
|PubMed|2009|611
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
|Patient Preference and Adherence|2017|325
Collaborative Care for Bipolar Disorder: Part II. Impact on Clinical Outcome, Function, and Costs
|Psychiatric Services|2006|315